Atara Biotherapeutics and Pierre Fabre Laboratories Announce

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Denver , Colorado , United States , Ukraine , France , Castres , Midi Pyrées , Boston , Massachusetts , California , Dana Farber Cancer Institute , French , American , Laurence Marchal , Pierre Fabre Laboratorie , Pierre Fabre , Pascal Touchon , Prix Galien , Alex Chapman , Susan Prockop , American Society Of Clinical Oncology , Drug Administration , Pierre Fabre Foundation , Atara Biotherapeutics Inc , Corporate Communications Investor Relations , American Society Of Hematology , European Union , Linkedin , Exchange Commission , Securities Exchange , European Commission , Nasdaq , First Phase , Allogeneict Cell , Objective Response Rate , Median Duration , Strong Clinical , Pierre Fabre Laboratories , Chief Executive Officer , Lancet Oncology , Clinical Oncology , Boston Children , Hospital Dana Farber Cancer , Middle East , Medical Affairs , Fabre Laboratories , Fabre Laboratorie , Securities Act , Securities Exchange Act , Southern California , Financial Condition , Media Relations , Corporate Communications , Investor Relations , Fabre Laboratories Media Contact ,